Frontlight ResearchEarly access
CompletedNo phase
Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy
Key facts
- Who runs it
- Ukraine Association of Biobank
- Where
- Ukraine1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 86 people enrolled
- Started
- 1 Sept 2020
- Ended
- 30 Sept 2025
- Type of study
- Observational
- Treatments tested
- Observational
- Record updated
- 22 December 2025
Who can take part
- Age
- 18 years to 40 years
- Sex
- Women only
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Provision of written informed consent for this study by subjects or as applicable parent legal guardian. Treated with drug product for therapy of premature ovarian insufficiency in a Institute Bio-Stem Cell Rehabilitation UAB clinical study
- Diagnosed of premature ovarian insufficiency ESHRE:
- Women age of 18 to 40 years
- Have experienced 4 months of oligo/amenorrhea
- Two serum follicle-stimulating hormone (FSH was >40 mIU/ml levels in the menopausal range, obtained at least a month apart
- lower FSH levels ( 25 mIU/ml)
- anti-Müllerian hormone (AMH) serum levels ( 3.0 ng/ml)
Who cannot take part
- There are no exclusion criteria for this study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a multi-centers of long term safety and efficacy follow up study for patients with premature ovarian failure (the women aged younger than 40 years, who present with amenorrhoea, hypergonadotropic hypogonadism, and infertility) who have been treated with ex vivo gene therapy drug product in Institute of Bio-Stem Cell Rehabilitation UAB - sponsored clinical studies. After completing the parent clinical study (approximately 6 month), eligible subject will be followed for additional 2 years for total of 2 years and 6 month post drug product infusion. No investigation drug product will be administered in the study
Treatments tested
- Observational
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy Using Autologous Mesenchymal Stem Cell and Mesenchymal Stem Cell Lyophilisate
- Record updated
- 22 December 2025